bioRxiv Science⌕ Search

Biology subjects

Jiang, X.

Publications and source records attributed to Jiang, X..

At least 37 records · Page 2Linked to original sources

Double Machine Learning with Multi-Gene Shared Backgroundfor Causal Inference in Single-Cell Data: Grouping Deviation Follows a Random Walk and the Accuracy-Compute Trade-Off

In high-throughput single-cell transcriptomics (p {approx} 20,000 genes), performing double machine learning (DML) causal inference on q {approx} 5,000 target genes requires nuisance function fits that grow linearly with the number of targets (Kf cross-fitting folds, Kf = 5 or 10), far exceeding feasible computational budgets, especially with deep learning. We propose a Randomized Partition Strategy (RPS): randomly divide target genes into groups, share one background compression per group, reducing deep learning model training to q/m runs (m = group size) --- a factor of m savings. The cost of grouping is accuracy loss --- we prove that the cumulative deviation of the estimator follows a one-dimensional drift-free symmetric random walk, with diffusion variance growing linearly with group size and mean squared displacement equaling the mean squared error, so accuracy loss is predictable: m = 1 is always optimal, accuracy cost is monotonically increasing, and a small accuracy sacrifice yields m-fold compute savings. On GSE189050 SLE single-cell data (Memory B cells, n = 2120), both PCA and DL methods converge to the same conclusion, confirming the random walk mechanism is method-independent; an unexpected finding is that DL diffusion growth is only 16%, far slower than PCAs 7.4 times. This work provides a quantifiable theoretical foundation for compute strategy selection in single-cell high-dimensional causal inference.

systems biology↗

Collaborative multi-agent intelligence uncovers subtype-selective allosteric sites at GPCR-lipid interaction interface

Closely related G protein-coupled receptor (GPCR) subtypes often share highly conserved orthosteric pockets, making subtype-selective ligand development challenging. Here, we developed a five-agent workflow to systematically identify divergent protein-membrane-interface sites across class A GPCRs and exploit them for selective allosteric ligand discovery. By combining dMaSIF-derived surface fingerprints with Ballesteros-Weinstein (BW) position alignment, we compared structurally equivalent membrane-facing regions and identified the three most divergent hotspots for each of 163 receptor pairs. These regions showed substantial spatial overlap with experimentally characterized allosteric sites. Paired target-off-target screening of one million lead-like compounds, followed by detail-mode redocking and multi-seed consistency filtering, yielded 352 receptor-pair-specific candidates corresponding to 344 unique compounds across 104 receptor pairs. These candidates, together with their divergent sites and predicted selectivity profiles, were integrated into a searchable database. Our findings establish a scalable strategy for translating GPCR membrane-interface divergence into precise allosteric sites and testable subtype-selective ligand candidates.

biochemistry↗

TOPII-targeting and MUS81 deficiency sensitise HER2-low tumour models to T-DXd

In this study, we identify Topoisomerase II (TopII ) targeting and MUS81 deficiency as sensitisers to trastuzumab deruxtecan (T-DXd), a HER2-targeting antibody-drug conjugate with a potent topoisomerase I poison payload that is of clinical importance in the treatment of HER2 expressing solid tumours in a range of cancer types. Using preclinical tumour spheroid models of breast and colorectal cancer, we show that TopII targeting with doxorubicin sensitises HER2-low tumour cells to T-DXd, elevating cell cytotoxicity, DNA damage, and checkpoint pathway activation. T-DXd treatment, both as a single agent and in combination with doxorubicin, increases TopII expression, highlighting this nuclear endonuclease as a potential candidate biomarker for T-DXd response in both the HER2-high and HER2-low setting. Using isogenic CRISPR models, we show that genetic loss of the MUS81 structure-specific endonuclease, a key processor of branched DNA structures and under-replicated DNA, sensitises HER2-low colorectal cancer cells to T-DXd. Given that reduced expression of MUS81 is closely related to metastasis and poor prognosis in colorectal carcinoma, our findings highlight the potential utility of these treatment combinations in a subset of colorectal cancer patients that present with HER2-positve/MUS81-low disease.

cancer biology↗

Beyond air-seeding: Dynamic, multiphase interactionsreveal a two-step mechanism of embolism propagation inangiosperm xylem

BackgroundThe mechanism underlying drought-induced embolism in angiosperm xylem has been attributed to air-seeding. This concept describes the bulk flow of gas from embolised to neighbouring conduits through the penetration of gas-liquid menisci across pores in interconduit pit membranes. While there is compelling evidence for the spatial propagation of embolism, air-seeding rests on various simplifying assumptions. Among others, air-seeding presumes that xylem sap has physical properties comparable to pure water, that pit membranes can be approximated as structures with simple pores, and that embolism occurs whenever a gas-liquid interface crosses a pit membrane. ScopeRecent experimental and theoretical work demonstrates that the biophysical conditions and processes governing gas-liquid interactions at interconduit pit membranes are fundamentally more dynamic and complex than assumed by air-seeding. These phenomena include: (1) gas movement through constriction pore networks, (2) insoluble, polar lipids at conduit surfaces and interfaces, (3) dynamic surface tension of xylem sap that depends on the local packing density of interfacial lipids, (4) bubble snap-off dynamics within pit membranes, (5) surfactant-stabilized nanobubbles in sap that is oversaturated with dissolved gas, and (6) electrostatic interactions between charged interfaces. Importantly, embolism propagation involves bubble generation and embolism formation as distinct, temporarily and spatially separated processes. Embolism formation occurs when nanobubbles become unstable, whereas nanobubbles below critical stability thresholds can remain stable in sap-filled conduits. ConclusionsTogether, these findings reconfirm that pit membranes function as safety valves enabling water transport according to the cohesion-tension theory, and provide mechanistic insights into embolism propagation. They address the question why plants do not suffer constant embolism formation despite negative xylem pressures. We conclude that a revised framework explicitly accounting for the 3D structure of pit membranes, and multiphase, dynamic processes operating within them are required to explain the biophysics underlying water transport and embolism resistance in angiosperm xylem.

plant biology↗

Structure of a key adhesin-exopolysaccharide interaction provides insights into matrix assembly in Vibrio cholerae biofilms

Biofilms serve as a protective mechanism for bacteria, including many pathogens. To form such communities, bacteria secrete macromolecules that form an extracellular matrix serving as a barrier against environmental threats, such as predation, antibiotics, and the host immune system. To be effective, a biofilm must anchor to foreign surfaces and retain sufficient stiffness, in the environment or in a host. However, how this matrix self-organizes to support biofilm formation remains a mystery at the molecular level. The human pathogen Vibrio cholerae produces biofilms primarily composed of an exopolysaccharide called VPS (Vibrio polysaccharide), consisting of an unusually-modified repeating tetrasaccharide core unit. VPS engages with two secreted adhesion proteins, Bap1 and RbmC, which adhere the biofilm to abiotic and biotic surfaces, and serve to strengthen the biofilm by interacting with VPS using a conserved {beta}-propeller. To pinpoint the interaction between the adhesins and purified segments of VPS, we determined the [~]1.6 [A] X-ray crystal structure of Bap1 bound to fragmented VPS and used the structure to carry out molecular dynamics simulations. The structure revealed a single binding site consisting of one tetrasaccharide unit involving an induced magnesium binding site. Unexpectedly, the tetrasaccharide adopted a bent state caused by a rotation of the glycosidic bond between the central two monosaccharide units. Using a combination of mutagenesis, light scattering, and in situ fluorescent microscopy, we demonstrate that Bap1 not only facilitates biofilm adhesion, but is also required for proper VPS organization, through the identified binding pocket. Our structure reveals for the first time the interaction between a biofilm exopolysaccharide and matrix protein, as well as insights into conformational changes of exopolysaccharide induced by this binding. Our findings provide a generalizable approach for studying the biophysical and biochemical properties of carbohydrate-dependent biofilm assembly, which may lead to new ways to treat disease caused by biofilm-forming bacterial pathogens by disrupting the exopolysaccharide-protein interactions.

microbiology↗

Beyond Generic Signal Peptides: ApexSP Enables Cargo-Specific Secretion Design

Recombinant proteins are widely used in biopharmaceuticals, industrial manufacturing, and molecular diagnostics; however, efficient secretion remains a major bottleneck limiting their large scale production. As core elements controlling protein entry into secretion pathways, signal peptides do not function solely based on their own sequences, but rather depend on coordinated compatibility among cargo protein properties, secretion pathways, and host backgrounds. Current signal peptide engineering mainly relies on a limited number of commonly used signal peptides, empirical selection, and individual experimental screening, making it difficult to design efficient secretion elements tailored to specific expression systems. Here, we present ApexSP, a signal peptide design framework for secretion engineering tailored to individual cargo proteins. ApexSP is built upon a large scale, high quality signal peptide knowledge base and integrates a discrete diffusion generative model constrained by evolutionary information, a multitask biological filter incorporating topology information, and a signal peptide and mature protein compatibility ranking model to enable integrated design of signal peptides for specific expression systems. ApexSP achieved high accuracy in multiple attribute prediction tasks, including pathway classification and cleavage site prediction, reaching or exceeding the performance of existing signal peptide prediction tools. Moreover, the cargo protein aware ranking module improved the enrichment of candidates with high secretion performance. Experimental validation across multiple eukaryotic and prokaryotic expression systems demonstrated that screening only 10 candidate sequences generated by ApexSP yielded multiple designed signal peptides outperforming reference signal peptides, with the best performing design in the ApGA expressed Pichia pastoris system achieving a 1.71 fold increase in secretion performance compared with the factor signal peptide. Overall, ApexSP advances signal peptide research from sequence prediction toward secretion element design, demonstrating that a single round of designed signal peptides can achieve high secretion performance suitable for further engineering optimization.

synthetic biology↗

Comparison of nuisance function construction strategies for double machine learning causal inference in single-cell transcriptomics: shared unsupervised deep learning does not require cross-fitting

Inferring "whether a change in the expression of a given gene causally affects the disease state" from observational single-cell transcriptomic data is one of the central problems in single-cell biology. The difficulty lies in confounding: cell state, batch, cell cycle, and the co-expression of other genes may all simultaneously influence the target gene (treatment variable T) and the disease label (outcome variable Y), so that naive correlation analysis cannot distinguish causation from covariation. Double machine learning (DML), via orthogonal scores and cross-fitting, allows machine learning to estimate high-dimensional nuisance functions, thereby addressing the causal inference problem in high-dimensional data. Constrained by computational resources, this study takes a small-sample dataset with p{approx}n (2,120 cells, 1,999 background genes) as the experimental testbed and systematically compares three nuisance function construction strategies under this critical condition; strategies for the n>>p regime are then addressed by theoretical argument. Using systemic lupus erythematosus (SLE) peripheral blood memory B cells (GSE189050, 2,120 cells), we construct a three nuisance function construction strategies x (in-sample / cross-fitting) 2x3 factorial experiment and compare them in terms of resolution, biological plausibility, stability, and deconfounding ability in causal effect estimation. The three strategies are: (S1) direct linear nuisance regression on the high-dimensional background genes without dimensionality reduction; (S2) learning a shared low-dimensional representation with an unsupervised autoencoder, with the treatment and outcome residuals sharing that representation; (S3) fitting the treatment and outcome with two independent deep networks. The results yield a clear three-part pattern with mechanistic meaning: (1) both modes of S1 fail; (2) S2 achieves the optimum in-sample and requires no cross-fitting; (3) S3 is "rescued" under cross-fitting and becomes effective. We explain this pattern starting from the convergence rate condition of DML (Sec.5 Theoretical Foundations) and give the applicability boundaries of the two strategies: S2 (shared unsupervised deep learning) achieves estimation quality comparable to standard cross-fitted DML at a tiny fraction of the computational cost, making it a feasible scheme for large-scale screening; S3 (dual networks + cross-fitting), as the standard DML recipe, can serve as a broad-spectrum reference control for S2 results.

systems biology↗

MetaClaw: an auditable AI agent for end-to-end, multi-directional metagenomic and multi-omics analysis

End-to-end omics analysis requires more than selecting tools: a usable agent must bind data correctly, execute long workflows without blocking, preserve provenance and recover the biological conclusions that motivate an analysis. Existing LLM-driven bioinformatics agents automate parts of this process, but their operational dependencies and conclusion-level validity are often unclear. Here we present MetaClaw, an auditable agent that maps a user request to a registered workflow, executes standardized upstream processing on FlowHub, and runs study-specific downstream analyses in network-isolated OpenClaw containers. A YAML registry and an explicit plan-submit-poll-finalise lifecycle record file bindings, parameters, scripts, environments and outputs in per-job bundles. Across the full cohorts of four published studies (769 metagenomic profiles), MetaClaw recovered 4/4 sorghum marker groups, 3/3 RRMS features, 4/5 canonical CRC markers among the top 20 classifier features and 5/5 permafrost marker groups. In 45 model-by-prompt runs, upstream completion was consistent whereas downstream validity depended on the backend and instruction detail; three decoy-tested endpoints showed no significant differences. In 48 ablation sessions, removing the registry, planning loop or manifest caused distinct losses, with registry removal increasing time, tool calls and token cost. MetaClaw therefore connects standardized upstream execution, local analytical flexibility and conclusion-level validation in a rerunnable framework for metagenomic and microbiome multi-omics analysis.

bioinformatics↗

Network-scale disruption of RNA-protein interactions by a bioaccumulating small-molecule drug

Many small-molecule drugs accumulate in both host and gut microbial cells. Yet, the molecular consequences of intracellular drug accumulation are largely unknown. Here we show that the antidepressant duloxetine broadly disrupts RNA-protein interactions revealing a previously unrecognized mode of drug effect. Across phylogenetically diverse bacteria and human intestinal cells, duloxetine consistently reduced RNA-binding capacity, with approximately 80% of RNA-binding proteins responding to duloxetine in bacteria (E. coli IAI1) and human (Caco-2) cells. As a mechanistic example, we show how duloxetine disrupts interactions between the pyrimidine biosynthesis enzyme PyrB and transcripts encoding metabolically linked functions. Biochemical and structural analyses show that duloxetine competes with aspartate, the natural substrate of PyrB, weakening the enzymes binding with 3' UTR-localized stem-loop structures in its RNA partners. Overall, our results uncover the off-target disruption of RNA-protein interactions due to drug accumulation and have implications for understanding molecular basis of variation in drug efficacy and toxicity.

systems biology↗

Accumulation of Lipid Droplets in Microglia following Neonatal Brain Hypoxia-Ischemia

BackgroundHypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal mortality and neurodevelopmental impairments. Following brain hypoxia-ischemia (HI), microglia face substantial metabolic stress; and upon phagocytosis, they become overloaded with lipids derived from engulfed dead neurons and myelin debris. It is unclear how microglia respond to and process the lipid cargo, and whether lipid accumulation may affect microglia function following neonatal HI. MethodsThe postnatal day 10 mice were subjected to HI using the Vannucci model. Lipid droplets (LD) were assessed by histology and immunofluorescent staining. Single-nucleus RNA sequencing (snRNA-seq) was performed using brain tissue from HI-injured and sham-operated mice at 72 hours after HI. LD-accumulating microglia (LDAM) were identified by a specific LD marker gene perilipin 2 (Plin2). Differential gene expression was analyzed between Plin2-positive and Plin2-negative microglia after HI. Human HIE brain sections were also examined for LD accumulation. The dynamic changes of PLIN2-expressing microglia and infiltrating monocyte-derived macrophages (MDM) at 24 hours, 72 hours and 7 days after HI were compared using flow cytometry. In addition, mouse BV2 microglia were subjected to oxygen-glucose deprivation (OGD) to study phagocytosis and cytokine expression. ResultsLipid droplets accumulated primarily in microglia after HI in neonatal mice and in human HIE brain. LD were not found in astrocytes or neurons. Plin2-expressing LDAM emerged as new microglia clusters after HI. Compared with microglia without LD, LDAM showed a distinct transcriptional profile with upregulation of genes linked to microglial activation, enhanced cholesterol and lipid processing, and a shift towards phagocytic and pro-inflammatory state. Blocking LD biogenesis reduced elevated phagocytosis and IL-1{beta} expression in BV2 cells following OGD. ConclusionOur study revealed that microglia accumulate lipid droplets as part of their metabolic responses to HI in the neonatal brain. Microglial lipid droplet formation is associated with a pro-inflammatory phenotype at early stage after HI, and increased phagocytosis in vitro. The lipid metabolic changes may regulate microglial function and influence HI outcomes.

neuroscience↗

A long-hidden prevalent PCR artifact and its application in DNA library screening

PCR artifacts can lead to aberrant DNA products and confound result interpretation, posing significant challenges in research and diagnostics. Traditionally, it has been blamed to misannealing of primers on unintended sites. However, by sequencing, we find that most PCR byproducts and artifacts actually have both primers bound correctly but lack a middle part of the target, a phenomenon we named as PCR leaping. The leaping occurs at random positions, is independent of sequence repeats and requires a single piece template, indicating an unprecedented mechanism. It is observed with various polymerases, template qualities, GC contents, and PCR programs, thus necessitating a reset of our PCR understanding and careful consideration in future studies, for example in CRISPR editing validations. On the other hand, it provides a simple way of DNA end pairing, based on which we develop a high throughput DNA library screening method for natural product discovery at substantially reduced cost.

molecular biology↗

Convergent Inhibitory Cortical Circuit Disruption Drives Genetically Distinct Absence Seizures

Childhood absence epilepsy is one of the most common pediatric epilepsies, characterized by brief involuntary lapse in consciousness and generalized spike-wave discharges (SWDs) on EEG. Despite a growing list of causative genes, the core cortical circuit abnormalities driving this highly stereotyped SWD phenotype remain elusive. Using two well-established absence epilepsy mouse models carrying point mutations in distinct genes altering pre and postsynaptic transmission, stargazer (Cacng2) and tottering (Cacna1a), we show that a specific translaminar inhibitory microcircuit defined by layer 6 corticothalamic neurons (L6 CT) and a novel Tac1+ Pvalb interneuron subtype is disrupted in both models. This early functional defect was followed by a secondary, marked dysfunction of deep-layer somatostatin-expressing (Sst) interneurons that coincides with the postnatal developmental onset of seizures. Crucially, we established the serial causality of these cascading defects by demonstrating that chemogenetic disruption of the L6 CT-Tac1+ Pvalb microcircuit alone in wild-type mice is sufficient to induce both the secondary Sst interneuron dysfunction and contemporaneous emergence of SWDs. Together, these findings reveal a sequential translaminar synaptic dysfunction or domino effect wherein a primary cell-autonomous defect triggers broader circuit adaptations permitting spike-wave hypersynchrony. Our results thus identify a convergent, causative cortical circuit pathology across two genetically heterogeneous absence epilepsy models, highlighting a common functional target for intervention

neuroscience↗

A superfolding sfPepper enables superresolution and single-molecule RNA imaging in live cells

Fluorescent RNAs (FRs) have emerged as powerful tools for the visualization of RNA in live cells. However, the poor folding of FRs is a major limiting factor in many advanced RNA imaging applications. Here, we describe a novel strategy to significantly increase the folding efficiency of FRs. By introducing a stabilizing stem and performing targeted mutagenesis at key junction regions, we develop a superfolder variant of the Pepper aptamer, termed sfPepper, that exhibits a striking twofold increase in folding efficiency compared with Pepper under physiological conditions. sfPepper exhibits much improved thermostability and reduced ion dependence and, most importantly, is substantially brighter than Pepper in live cells. sfPepper enables robust imaging of diverse noncoding RNAs and messenger RNAs with increased signal-to-background ratios and stimulated emission depletion (STED) superresolution imaging of CUG trinucleotide repeat-containing toxic RNAs. Remarkably, only four sfPepper repeats facilitate sensitive single-molecule mRNA tracking, revealing dynamic heterogeneity among ER-associated mRNA molecules. Together, this study establishes an efficient strategy for improving FR folding and offers a powerful tool for fluorescently labelling RNAs in live cells.

molecular biology↗

Laboratory evolution enhances resilience of a symbiont yeast and its honeybee host against agrochemical exposure

Yeasts are key microbial members of several ecosystems. Yet, the impact of widespread chemical pollutants on yeasts is only sparsely studied. Here we report the effect of >1000 chemical pollutants on fourteen diverse yeast species spanning the Saccharomycotina subphylum. Starmerella bombicola, a symbiont of various bee species, was the most sensitive and inhibited by several fungicides as well as by non-fungicides. To identify the molecular basis of this ultra-sensitivity, we selected resistant lineages against nine chemicals using adaptive laboratory evolution. Whole-genome-sequencing uncovered convergent evolution on YBP1, a key regulator of oxidative stress. Proteomic analysis confirmed the protective role of oxidative stress response pathways, including proteins encoded by horizontally transferred bacterial genes. We find that the evolved S. bombicola stably colonized the bee gut and ameliorated the negative effect of paclobutrazol, a plant hormone regulator, on gut microbes, sucrose responsiveness, and learning. Our findings demonstrate how laboratory evolution can be used to mitigate the negative impact of chemical pollutants on pollinators.

microbiology↗

TCR-FramePose: a local-frame representation for decomposing global docking and CDR3 loop geometry in TCR-pMHC recognition

T cell receptor recognition of peptide-MHC depends on sequence, interface chemistry, and three-dimensional geometry, but docking geometry is often summarized at the whole-receptor level, leaving CDR3-local pose difficult to compare across structures. We introduce TCR-FramePose, a local-frame descriptor set that represents each TCR-pMHC complex as three bodies -- whole TCR, CDR3, and CDR3{beta} -- measured relative to a pMHC groove frame. For each body, FramePose decomposes the native pose into reach, offset direction on S2, and orientation on SO(3); for tangent-space analyses, these components are mapped to six coordinates per body and 18 coordinates per complex. Applied to 378 curated {beta}TCR-pMHC crystal structures, FramePose recovers known class-associated receptor-placement differences and additionally resolved whole-TCR and CDR3{beta} orientation shifts that were not captured by crossing angle. The same orientation coordinates identified reverse-polarity and off-axis outliers as distinct modes. In cross-validated association analyses, FramePose added nonredundant BSA- and affinity-associated information beyond conventional descriptors, and the modest affinity gain was concentrated in CDR3 orientation blocks which were least recoverable from conventional descriptors. Biological grouping analyses showed that shared receptor pose over peptide-MHC was organized primarily by germline V-region framework. TCRs recognizing the same peptide-MHC target favors shared FramePose geometries rather than strong receptor-specific divergence, whereas CDR3 sequence did not detectably reposition the rigid-body pose after antigen context and germline framework were fixed. MHC allele and peptide length contributed smaller adjustments, localized mainly to CDR3{beta} and groove-normal orientation axes. Finally, interface analyses showed that affinity tracked interface burial, with CDR3{beta} reach linking FramePose geometry to binding through buried surface area. Within engineered panels, mutation-level effects were panel-specific, with CDR3{beta} remodeling localizing to a recurrent interface region but varying in direction across receptors. These properties enable FramePose to serve as a geometric filter for in silico TCR-pMHC models and as a feature layer for structure-guided TCR engineering. Together, TCR-FramePose provides a nonredundant geometric layer for structure-guided TCR-pMHC analysis, linking germline-scaffolded recognition, CDR3-local pose, and interface organization without replacing sequence, contact, or energetic descriptors.

bioinformatics↗

Microfluidic Tissue Array Platform for Personalized Drug Screening Using Tumor Explants or Biopsies

Despite major improvements in molecular characterization of breast cancer, current biomarkers still fall short in accurate treatment prediction. Interrogating tumor tissue ex-vivo in its native conformation is a direct strategy for guiding treatment of individual patients but presents a challenge. In this study, we developed a microfluidic tissue array (FTA) using small biopsy samples (< 1mm3) mimicking physiological flow for consistent exchange of nutrients and waste, retaining the tumor native stroma. Cell/patient-derived breast cancer xenograft tissues were maintained over 2 weeks in the array and their response to therapeutic agents, doxorubicin or neratinib, were interrogated. Drug response in the uFTA showed >2-fold reduction in tumor cell viability which corroborated tumor size shrinkage in mice bearing the same tumor load. EdU/Ki67 assays indicated selective retention of cells with higher proliferative capacity after drug treatment, underscoring in vivo clinical relevance . We have also developed a valved-FTA to increase throughput and variety of treatment conditions on the same chip. Together, this FTA can be staged as a powerful, low-cost benchtop theranostic tool for personalized cancer therapeutics compatible with FDAs New Approach Methods.

cancer biology↗

A Glutamine antagonist-modulated tumor microenvironment unleashes enzalutamides immunotherapeutic effects

Androgen receptor (AR) antagonists, such as enzalutamide, suppress prostate cancer (PCa) cells to achieve temporary therapeutic effects. In addition to tumor cell-autonomous suppressive function, AR antagonists can also potentially exert anti-tumor effects via mitigating cytotoxic T cells exhaustion. However, strategies for effectively harnessing enzalutamides immunotherapeutic effects remain elusive. In studying a recently described glutamine antagonist prodrug (DRP-104) in PCa models, we found that despite the initial response, tumors ultimately became resistant. Intriguingly, compared to the untreated (DRP-104 treatment-naive) tumors, the resistant tumors became highly susceptible to enzalutamide in vivo. Additionally, treating tumors with DRP-104 and enzalutamide simultaneously also yielded superior therapeutic efficacy. We demonstrated that DRP-104 therapy promoted the infiltration of CD8+ T cells as well as regulatory T cells (Treg) in responsive tumors, and the tumor-infiltrating Treg were mostly depleted upon enzalutamide treatments. Mechanistically, we showed that Treg differentiation from mouse CD4+ T cells was attenuated by enzalutamide. We further demonstrated that Treg induction was accompanied by the interaction between AR and aryl hydrocarbon receptor (AhR), the nuclear receptor indispensable for Treg differentiation, in the nuclei of CD4+ T cells, and this interaction was diminished by enzalutamide. In further support of AR signaling in Treg biogenesis, analysis of available gene expression datasets found that AR expression was elevated in Treg when compared to CD4+ T cells in human peripheral blood mononuclear cells (PBMCs). In addition, it was positively correlated with Treg module scores in several human cancer types. Finally, using an anti-GPC3 (Glypican 3) vaccination model, we demonstrated that CD4+ T cells subjected to Treg induction in the presence of enzalutamide were less effective in protecting GPC3-expressing tumor cells from CD8+ T cells cytotoxic killing. Collectively, these results suggest that AR promotes Treg s differentiation and/or immunosuppressive functions, and nominate enzalutamide as a Treg-mitigating agent for potentiating immunotherapies. Our results also demonstrate that an otherwise unintended, Treg-promoting property of DRP-104 can be leveraged to unleash the immune-regulatory function of enzalutamide for the treatment of PCa.

cancer biology↗

Practical Use of Advanced AI Frameworks on Real-Life Scientific Problems: Three Case Studies

Agentic artificial intelligence (AI) systems increasingly claim to automate scientific research, yet independent evaluations report persistent gaps between those claims and demonstrated capability. We tested frontier agentic AI systems on three practical problems: prediction of treatment non-response in immune-mediated inflammatory diseases, optical chemical structure recognition for literature mining, and prediction of drug-design-related properties from small datasets. Each problem was first assigned to autonomous frameworks and then reattempted as human-led, AI-assisted work. Autonomous runs failed in most cases, while human-led work produced reusable resources and modest but defensible performance, including new evidence for possible mechanisms of treatment resistance and a more practical benchmark for mining chemical structures from scientific papers. Property prediction was the single task on which one autonomous AI framework matched the human expert. We conclude that current frameworks can carry out engineering and analysis once a human expert leads the project, but cannot yet engineer a novel solution without oversight. The use of AI on real-life scientific problems remains an art rather than a routine technology.

bioinformatics↗